BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18779341)

  • 1. Outer surface protein A protects Lyme disease spirochetes from acquired host immunity in the tick vector.
    Battisti JM; Bono JL; Rosa PA; Schrumpf ME; Schwan TG; Policastro PF
    Infect Immun; 2008 Nov; 76(11):5228-37. PubMed ID: 18779341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
    de Silva AM; Telford SR; Brunet LR; Barthold SW; Fikrig E
    J Exp Med; 1996 Jan; 183(1):271-5. PubMed ID: 8551231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of outer surface protein A by Borrelia burgdorferi during transmission from infected mammals to feeding ticks is insufficient to trigger OspA seroconversion.
    Woodman ME; Cooley AE; Stevenson B
    FEMS Immunol Med Microbiol; 2008 Nov; 54(2):277-82. PubMed ID: 18793197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Equivalence of OspA and OspB, but Not OspC, in Tick Colonization by Borrelia burgdorferi.
    Tilly K; Bestor A; Rosa PA
    Infect Immun; 2016 May; 84(5):1565-1573. PubMed ID: 26953324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
    Izac JR; Oliver LD; Earnhart CG; Marconi RT
    Vaccine; 2017 May; 35(24):3178-3185. PubMed ID: 28479174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection of mice with lyme disease spirochetes constitutively producing outer surface proteins a and B.
    Strother KO; Hodzic E; Barthold SW; de Silva AM
    Infect Immun; 2007 Jun; 75(6):2786-94. PubMed ID: 17371860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OspA immunization decreases transmission of Borrelia burgdorferi spirochetes from infected Peromyscus leucopus mice to larval Ixodes scapularis ticks.
    Tsao J; Barbour AG; Luke CJ; Fikrig E; Fish D
    Vector Borne Zoonotic Dis; 2001; 1(1):65-74. PubMed ID: 12653137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reductions in human Lyme disease risk due to the effects of oral vaccination on tick-to-mouse and mouse-to-tick transmission.
    Voordouw MJ; Tupper H; Önder Ö; Devevey G; Graves CJ; Kemps BD; Brisson D
    Vector Borne Zoonotic Dis; 2013 Apr; 13(4):203-14. PubMed ID: 23428088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.
    Zhong W; Gern L; Kramer M; Wallich R; Simon MM
    Eur J Immunol; 1997 Nov; 27(11):2942-7. PubMed ID: 9394822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does host complement kill Borrelia burgdorferi within ticks?
    Rathinavelu S; Broadwater A; de Silva AM
    Infect Immun; 2003 Feb; 71(2):822-9. PubMed ID: 12540562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of OspA monoclonal antibody C3.78 with Borrelia burgdorferi within ticks.
    Gipson CL; de Silva AM
    Infect Immun; 2005 Mar; 73(3):1644-7. PubMed ID: 15731064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
    Scheckelhoff MR; Telford SR; Hu LT
    Vaccine; 2006 Mar; 24(11):1949-57. PubMed ID: 16300863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.
    Pal U; Montgomery RR; Lusitani D; Voet P; Weynants V; Malawista SE; Lobet Y; Fikrig E
    J Immunol; 2001 Jun; 166(12):7398-403. PubMed ID: 11390491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Borrelia burgdorferi outer surface protein (osp) B expression independent of ospA.
    Liang FT; Caimano MJ; Radolf JD; Fikrig E
    Microb Pathog; 2004 Jul; 37(1):35-40. PubMed ID: 15194158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice.
    Schwan TG; Piesman J
    J Clin Microbiol; 2000 Jan; 38(1):382-8. PubMed ID: 10618120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of outer surface protein A antibody on Borrelia burgdorferi within feeding ticks.
    de Silva AM; Zeidner NS; Zhang Y; Dolan MC; Piesman J; Fikrig E
    Infect Immun; 1999 Jan; 67(1):30-5. PubMed ID: 9864192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reservoir targeted vaccine for lyme borreliosis induces a yearlong, neutralizing antibody response to OspA in white-footed mice.
    Meirelles Richer L; Aroso M; Contente-Cuomo T; Ivanova L; Gomes-Solecki M
    Clin Vaccine Immunol; 2011 Nov; 18(11):1809-16. PubMed ID: 21918116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
    Eschner AK; Mugnai K
    Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice.
    Fikrig E; Telford SR; Barthold SW; Kantor FS; Spielman A; Flavell RA
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5418-21. PubMed ID: 1608951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to tick-borne spirochete challenge induced by Borrelia burgdorferi strains that differ in expression of outer surface proteins.
    Kurtti TJ; Munderloh UG; Hughes CA; Engstrom SM; Johnson RC
    Infect Immun; 1996 Oct; 64(10):4148-53. PubMed ID: 8926082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.